Should SARS-CoV-2 serological testing be used in the decision to deliver a COVID-19 vaccine booster? A pro-con assessment

  1. Augello, M.
  2. Wagenhäuser, I.
  3. Krone, M.
  4. Dauby, N.
  5. Ferrara, P.
  6. Sabbatucci, M.
  7. Ruta, S.
  8. Rezahosseini, O.
  9. Velikov, P.
  10. Gkrania-Klotsas, E.
  11. Montes, J.
  12. Franco-Paredes, C.
  13. Goodman, A.L.
  14. Küçükkaya, S.
  15. Tuells, J.
  16. Harboe, Z.B.
  17. Epaulard, O.
Aldizkaria:
Vaccine

ISSN: 1873-2518,  0264-410X

Argitalpen urtea: 2024

Alea: 42

Zenbakia: 25

Mota: Berrikuspena

DOI: 10.1016/J.VACCINE.2024.126184 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus